Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Improving Public Cancer Care by Implementing Precision Medicine in Norway
- Status
- RECRUITING
- Phase
- PHASE2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
- Status
- TERMINATED
- Phase
- NA
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib With or Without Atezolizumab for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE3
Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2